“…The feasibility of both SAF and real-time teledermatopathology has already been proven in previous studies, mainly on nonmelanoma skin cancer or on melanocytic lesions, with less emphasis on inflammatory skin diseases [1,[6][7][8][9][10][11]. These studies suggest that diagnostic efficacy and accuracy in teledermatopathology may be particularly weak when examining entities that require the identification of subtle architectural arrangements or delicate cytologic features, as in inflammatory skin diseases [1,[6][7][8][9][10][11].…”